Next Article in Journal
The Different Strategies for the Radiolabeling of [211At]-Astatinated Radiopharmaceuticals
Next Article in Special Issue
Assessing Drug–Drug Interaction and Food Effect for BCS Class 2 Compound BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma Antagonist, Bevurogant) Using a Physiology-Based Pharmacokinetics Modeling (PBPK) Approach with Semi-Mechanistic Absorption
Previous Article in Journal
Applicability of MDR1 Overexpressing Abcb1KO-MDCKII Cell Lines for Investigating In Vitro Species Differences and Brain Penetration Prediction
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(6), 737; https://doi.org/10.3390/pharmaceutics16060737
Action Date Notes Link
article xml file uploaded 30 May 2024 08:03 CEST Original file -
article xml uploaded. 30 May 2024 08:03 CEST Update https://www.mdpi.com/1999-4923/16/6/737/xml
article pdf uploaded. 30 May 2024 08:03 CEST Version of Record https://www.mdpi.com/1999-4923/16/6/737/pdf
article supplementary file uploaded. 30 May 2024 08:03 CEST - https://www.mdpi.com/1999-4923/16/6/737#supplementary
article html file updated 30 May 2024 08:04 CEST Original file https://www.mdpi.com/1999-4923/16/6/737/html
Back to TopTop